Integrated Annual Report

Overview

The report describes Torrent Pharma's fourth integrated-report series within its 49th annual-report cycle, covering FY 2021-22 performance across India and overseas operations. It highlights a structured Growth with Sustainability strategy, GRI Core reporting, materiality assessment and Board-level sustainability oversight. Environmental disclosures include Scope 1 and Scope 2 emissions, energy, water and waste performance, alongside a target to reduce Scope 1 and Scope 2 emissions by 21% from 2020 levels by 2025. The report also introduces the company's first BRSR and details community healthcare, education and social-development programs.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2021-2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services